Concepedia

Bainan Wu

BW

25

Publications

1.4K

Citations

21

H-Index

2003

Active since

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

Virginia Commonwealth University

Torrey Pines Institute For Molecular Studies

University of California San Diego

St. Jude Children's Research Hospital

Bainan Wu is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

2003–2022

25

Publications

25

Key Residues Responsible for Acyl Carrier Protein and β-Ketoacyl-Acyl Carrier Protein Reductase (FabG) Interaction

Yongmei Zhang, Bainan Wu, Jie Zheng et al. · Journal of Biological Chemistry · 2003 · 144 citations · Full text

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to <i>mda</i> -7/IL-24–mediated toxicity

Rupesh Dash, Belal Azab, Bridget A. Quinn et al. · Proceedings of the National Academy of Sciences · 2011 · 123 citations

BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins

Jun Wei, John L. Stebbins, Shinichi Kitada et al. · Journal of Medicinal Chemistry · 2010 · 115 citations · Full text

, , +17

Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin

Timothy P. Kegelman, Bainan Wu, Swadesh K. Das et al. · Proceedings of the National Academy of Sciences · 2016 · 99 citations · Full text

New p32/gC1qR Ligands for Targeted Tumor Drug Delivery

Lauri Paasonen, Shweta Sharma, Gary B. Braun et al. · ChemBioChem · 2016 · 89 citations · Full text

Rows per page

1–5 of 25